SEATTLE GENETICS INC's ticker is SGENXXXX and the CUSIP is 812578102. A total of 299 filers reported holding SEATTLE GENETICS INC in Q1 2017. The put-call ratio across all filers is 0.82 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $412,000 | +47.7% | 2,105 | +28.4% | 0.04% | +33.3% |
| Q2 2020 | $279,000 | +862.1% | 1,640 | +556.0% | 0.03% | +725.0% |
| Q1 2020 | $29,000 | 0.0% | 250 | 0.0% | 0.00% | +33.3% |
| Q4 2019 | $29,000 | +3.6% | 250 | -23.1% | 0.00% | 0.0% |
| Q3 2019 | $28,000 | +460.0% | 325 | +333.3% | 0.00% | +200.0% |
| Q2 2019 | $5,000 | 0.0% | 75 | 0.0% | 0.00% | 0.0% |
| Q1 2019 | $5,000 | +25.0% | 75 | 0.0% | 0.00% | 0.0% |
| Q4 2018 | $4,000 | 0.0% | 75 | +50.0% | 0.00% | -50.0% |
| Q3 2018 | $4,000 | +33.3% | 50 | 0.0% | 0.00% | +100.0% |
| Q3 2017 | $3,000 | -99.9% | 50 | -50.0% | 0.00% | 0.0% |
| Q2 2017 | $5,000,000 | -28.6% | 100 | 0.0% | 0.00% | -50.0% |
| Q1 2017 | $7,000,000 | -12.5% | 100 | -33.3% | 0.00% | +100.0% |
| Q4 2016 | $8,000,000 | – | 150 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 50,060,240 | $5,775,950,000 | 35.57% |
| Lagoda Investment Management, L.P. | 72,969 | $8,419,000 | 9.97% |
| Avidity Partners Management LP | 580,000 | $66,920,000 | 9.25% |
| Arabesque Asset Management Ltd | 14,807 | $1,708,000 | 3.53% |
| Boxer Capital, LLC | 400,000 | $46,152,000 | 3.15% |
| Woodline Partners LP | 364,333 | $42,037,000 | 3.00% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 56,900 | $6,557,000 | 2.99% |
| SECTORAL ASSET MANAGEMENT INC | 107,000 | $12,346,000 | 2.37% |
| Capital International, Inc./CA/ | 1,197,659 | $138,186,000 | 2.33% |
| Bain Capital Public Equity Management II, LLC | 169,641 | $19,573,000 | 2.29% |